Shots:

• The company has launched Remdec at a price of $37.41 (Rs. 2800) for a 100mg lyophilized injection. The generic version is the most economical Remdesivir brand in India
• In Jun’2020- Zydus signed a non-exclusive agreement with Gilead to manufacture and commercialize Remdesivir for severe COVID-19 in India. The API of the therapy has been developed and manufactured at the group’s API manufacturing facilities in Gujarat
• The drug will be made available across India via Zydus’ strong distribution chain reaching out to government and private hospitals treating COVID patients

­ Ref: Zydus | Image: PharmaShots